by Daicel
CHIRALPAK AGP® has extremely broad applicability for the separation of chiral drugs.
The chiral selector is alpha1-acid glycoprotein (AGP). This very stable protein is immobilized onto spherical 5 micrometer silica particles. The protein-based columns function entirely in the reversed-phase hromatographic mode, using buffers with low organic modifier content and at moderate pH values.
The CHIRALPAK®AGP column separates enantiomers of an extremely broad range of drug compounds.
| Vendor | Daicel | Particle Size | |
| Brand | CHIRALPAK AGP | Length | |
| Modifification | Protein based on silica | Internal Diameter | |
| Mode | Reversed-Phase |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Daicel | CHIRALPAK CBH | Reversed-Phase | Protein based on silica | 10.0 mm | 100 mm | 5.0 μm | — | On request |
| Daicel | CHIRALPAK HSA | Reversed-Phase | Protein based on silica | 2.0 mm | 150 mm | 5.0 μm | — | On request |
| Daicel | CHIRALPAK AGP | Reversed-Phase | Protein based on silica | 2.0 mm | 150 mm | 5.0 μm | — | On request |
| Daicel | CHIRALPAK AGP | Reversed-Phase | Protein based on silica | 3.0 mm | 50 mm | 5.0 μm | — | On request |
| Daicel | CHIRALPAK CBH | Reversed-Phase | Protein based on silica | 2.0 mm | 100 mm | 5.0 μm | — | On request |
| Daicel | CHIRALPAK CBH | Reversed-Phase | Protein based on silica | 10.0 mm | 150 mm | 5.0 μm | — | On request |
| Daicel | CHIRALPAK HSA | Reversed-Phase | Protein based on silica | 2.0 mm | 50 mm | 5.0 μm | — | On request |
| Daicel | CHIRALPAK HSA | Reversed-Phase | Protein based on silica | 3.0 mm | 150 mm | 5.0 μm | — | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
